The relationship between gut microbiota and susceptibility to type 2 diabetes mellitus in rats

被引:5
|
作者
An, Yongcheng [1 ]
Dai, Hongyu [1 ]
Duan, Yuhui [1 ]
Cheng, Long [2 ]
Shi, Lu [1 ]
He, Changhao [1 ]
Wang, Chen [3 ]
Lv, Yinglan [1 ]
Li, Huimin [1 ]
Zhang, Huilin [1 ]
Huang, Yan [3 ]
Fu, Wanxin [3 ]
Sun, Weiguang [4 ]
Zhao, Baosheng [5 ]
机构
[1] Beijing Univ Chinese Med, Sch Chinese Materia Med, Dept Pharmacol, Beijing 102488, Peoples R China
[2] China Med Univ, Sch Pharm, Dept Pharmacognosy, Shenyang 110122, Peoples R China
[3] Beijing Univ Chinese Med, Sch Life Sci, Beijing 102488, Peoples R China
[4] Guangzhou Baiyunshan Xingqun Pharmaceut Co Ltd, Guangzhou 510288, Peoples R China
[5] Beijing Univ Chinese Med, Beijing Res Inst Chinese Med, Beijing 100029, Peoples R China
基金
中国国家自然科学基金;
关键词
Type 2 diabetes mellitus; Gut microbiota; 16S rRNA gene sequencing; Short-chain fatty acids; GPR41; GPR43; CHAIN FATTY-ACIDS; QUANTIFICATION;
D O I
10.1186/s13020-023-00717-9
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
PurposeThe purpose of this study is to investigate the relationship between the susceptibility to type 2 diabetes and gut microbiota in rats and to explore the potential mechanism involved.MethodsThirty-two SPF-grade SD rats were raised as donor rats, and divided into control, type 2 diabetes mellitus (T2DM, fasting blood glucose >= 11.1 mmol/L), and Non-T2DM (fasting blood glucose < 11.1 mmol/L) groups. Feces were collected and prepared as fecal bacteria supernatants Diab (fecal bacteria supernatant of T2DM group rats), Non (fecal bacteria supernatant of Non-T2DM group rats), and Con (fecal bacteria supernatant of control group rats). Another seventy-nine SPF-grade SD rats were separated into normal saline (NS) and antibiotics (ABX) groups and given normal saline and antibiotics solutions, respectively. In addition, the ABX group rats were randomly separated into ABX-ord (fed with a 4-week ordinary diet), ABX-fat (fed with a 4-week high-fat diet and STZ ip), FMT-Diab (with transplanted fecal bacteria supernatant Diab and fed with a 4-week high-fat diet and STZ ip), FMT-Non (with transplanted fecal bacteria supernatant Non and fed with a 4-week high-fat diet and STZ ip), and FMT-Con (with transplanted fecal bacteria supernatant Con and fed with a 4-week high-fat diet and STZ ip) groups. Furthermore, the NS group was randomly divided into NS-ord (fed with a 4-week ordinary diet) and NS-fat (fed with a 4-week high-fat diet and STZ ip) groups. After this, the short-chain fatty acids (SCFAs) in the feces were detected using gas chromatography, and the gut microbiota were detected using 16S rRNA gene sequencing. Finally, G protein-coupled receptor 41 (GPR41) and GPR43 were detected by western blot and quantitative real-time polymerase chain reaction.ResultsG__Ruminococcus_gnavus_group were more abundant in the FMT-Diab group compared to the ABX-fat and FMT-Non groups. The levels of blood glucose, serum insulin, total cholesterol, triglycerides, and low-density lipoprotein cholesterol were also higher in the FMT-Diab group compared to those of the ABX-fat group. Compared to the ABX-fat group, both the FMT-Diab and FMT-Non groups had higher contents of acetic and butyric acid, and the expression of GPR41/43 were significantly higher as well.ConclusionsG__Ruminococcus_gnavus_group might make rats more susceptible to T2DM; T2DM-susceptible flora transplantation increased the susceptibility to T2DM in rats. Additionally, gut microbiota-SCFAs-GPR41/43 may play a role in the development of T2DM. Lowering blood glucose by regulating gut microbiota may therefore become a new strategy for the treatment of T2DM in humans.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] (-)-Epicatechin ameliorates type 2 diabetes mellitus by reshaping the gut microbiota and Gut-Liver axis in GK rats
    Zeng, Hongzhe
    Liu, Changwei
    Wan, Liwei
    Peng, Liyuan
    Wen, Shuai
    Fang, Wenwen
    Chen, Hongyu
    Wang, Kuofei
    Yang, Xiaomei
    Huang, Jianan
    Liu, Zhonghua
    FOOD CHEMISTRY, 2024, 447
  • [22] Impact of the gut microbiota on the development of obesity and type 2 diabetes mellitus
    Moreno-Indias, Isabel
    Cardona, Fernando
    Tinahones, Francisco J.
    Isabel Queipo-Ortuno, Maria
    FRONTIERS IN MICROBIOLOGY, 2014, 5
  • [23] MECHANISMS IN ENDOCRINOLOGY Gut microbiota in patients with type 2 diabetes mellitus
    Allin, Kristine H.
    Nielsen, Trine
    Pedersen, Oluf
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 172 (04) : R167 - R177
  • [24] Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
    Zhang, Qi
    Hu, Nan
    DIABETES METABOLIC SYNDROME AND OBESITY, 2020, 13 : 5003 - 5014
  • [25] Gut microbiota and type 2 diabetes mellitus: a focus on the gut-brain axis
    Pan, Yi
    Bu, Tong
    Deng, Xia
    Jia, Jue
    Yuan, Guoyue
    ENDOCRINE, 2024, 84 (01) : 1 - 15
  • [26] Gut microbiota and type 2 diabetes mellitus: a focus on the gut-brain axis
    Yi Pan
    Tong Bu
    Xia Deng
    Jue Jia
    Guoyue Yuan
    Endocrine, 2024, 84 : 1 - 15
  • [27] The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus
    Lee, Chae Bin
    Chae, Soon Uk
    Jo, Seong Jun
    Jerng, Ui Min
    Bae, Soo Kyung
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (07)
  • [28] The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity
    Ningwen Tai
    F. Susan Wong
    Li Wen
    Reviews in Endocrine and Metabolic Disorders, 2015, 16 : 55 - 65
  • [29] Gut microbiota imbalances in Tunisian participants with type 1 and type 2 diabetes mellitus
    Fassatoui, Meriem
    Lopez-Siles, Mireia
    Diaz-Rizzolo, Diana A.
    Jmel, Haifa
    Naouali, Chokri
    Abdessalem, Ghaith
    Chikhaoui, Asma
    Nadal, Belen
    Jamoussi, Henda
    Abid, Abdelmajid
    Gomis, Ramon
    Abdelhak, Sonia
    Martinez-Medina, Margarita
    Kefi, Rym
    BIOSCIENCE REPORTS, 2019, 39
  • [30] The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity
    Tai, Ningwen
    Wong, F. Susan
    Wen, Li
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2015, 16 (01): : 55 - 65